TP53 c.316_317delinsGC ;(p.S106A)

Variant ID: 17-7579370-CT-GC

NM_000546.5(TP53):c.316_317delinsGC;(p.S106A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases.

Frontiers In Oncology
Alam, Manzar M; Ahmed, Sarfraz S; Elasbali, Abdelbaset Mohamed AM; Adnan, Mohd M; Alam, Shoaib S; Hassan, Md Imtaiyaz MI; Pasupuleti, Visweswara Rao VR
Publication Date: 2022

Variant appearance in text: p53: S106A
PubMed Link: 35359383
Variant Present in the following documents:
  • Main text
  • fonc-12-860508.pdf
View BVdb publication page



Phosphorylation of Puma modulates its apoptotic function by regulating protein stability.

Cell Death & Disease
Fricker, M M; O'Prey, J J; Tolkovsky, A M AM; Ryan, K M KM
Publication Date: 2010-07-29

Variant appearance in text: p53: S106A
PubMed Link: 21364664
Variant Present in the following documents:
  • Main text
  • cddis201038a.pdf
View BVdb publication page



Cleavage of Cdc6 by caspase-3 promotes ATM/ATR kinase-mediated apoptosis of HeLa cells.

The Journal Of Cell Biology
Yim, Hyungshin H; Hwang, In Sun IS; Choi, Joon-Seok JS; Chun, Kwang-Hoon KH; Jin, Ying Hua YH; Ham, Young-Mi YM; Lee, Kwang Youl KY; Lee, Seung Ki SK
Publication Date: 2006-07-03

Variant appearance in text: p53: S106A
PubMed Link: 16801388
Variant Present in the following documents:
  • Main text
  • jcb1740077.pdf
View BVdb publication page